Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Predicting Bariatric Surgery’s Ability to Cure T2D

JAMA Surg; ePub 2016 Apr 20; Wood, et al

Publish date:: April 29, 2016

Data from electronic health records might help predict patients in whom bariatric surgery will result in remission of type 2 diabetes, according to an analysis involving 407 individuals.

Participants—three-fourths of whom were female—averaged ~51 years of age. Investigators reviewed their EHR records up to 8 years following Roux-en-y gastric bypass. They looked at DiaRem score (calculated based on age, HBA_1C level, diabetes drugs used, and treatment with insulin) and extent of diabetes remission per ADA criteria. Among the results:

• 144 experienced 1 or more years of complete remission.

• 97 had partial remission lasting at least 1 year.

• 102 had prolonged partial remission.

• Remission occurred in 83.

The authors concluded that this approach can be used to improve the precision of care delivery.

Citation: Wood G, Mirshahi T, Still C, Hirsch A. Association of DiaRem score with cure of type 2 diabetes following bariatric surgery. [Published online ahead of print April 20, 2016]. JAMA Surg. doi:10.1001/jamasurg.2016.0251.

This Week's Must Reads

Higher dose maximizes effects of magnesium sulfate for obese women,

Microplastics permeate human placentas,

One in five gestational carriers do not meet ASRM criteria,

Gender surgical outcomes differ following puberty suppression,

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Must Reads in Diabetes

Sac/val heart failure benefit extends to diabetes patients,

Don’t miss cardiovascular risk factors in transgender patients,

Semaglutide shows promise in NASH phase 2 study,

‘Modest’ benefit for post-MI T2D glucose monitoring,

Diabetic neuropathic pain linked to brain bioenergic anomalies,